Starch Digestion-Related Amylase Genetic Variant Affects 2-Year Changes in Adiposity in Response to Weight-Loss Diets: The POUNDS Lost Trial.

Abstract

Salivary and pancreatic amylases (encoded by <i>AMY1</i> and <i>AMY2</i> genes, respectively) are responsible for digesting starchy foods. <i>AMY1</i> and <i>AMY2</i> show copy number variations that affect differences in amylase amount and activity, and <i>AMY1</i> copies have been associated with adiposity. We investigated whether genetic variants determining amylase gene copies are associated with 2-year changes in adiposity among 692 overweight and obese individuals who were randomly assigned to diets varying in macronutrient content. We found that changes in body weight (BW) and waist circumference (WC) were significantly different according to the <i>AMY1-AMY2</i> rs11185098 genotype. Individuals carrying the A allele (indicating higher amylase amount and activity) showed a greater reduction in BW and WC at 6, 12, 18, and 24 months than those without the A allele (<i>P</i> < 0.05 for all). The association was stronger for long-term changes compared with short-term changes of these outcomes. The genetic effects on these outcomes did not significantly differ across diet groups. In conclusion, the genetic variant determining starch metabolism influences the response to weight-loss dietary intervention. Overweight and obese individuals carrying the <i>AMY1-AMY2</i> rs11185098 genotype associated with higher amylase activity may have greater loss of adiposity during low-calorie diet interventions.